Codelivery of zoledronic acid and doublestranded RNA from core-shell nanoparticles

References

• AaproMSColemanREBone health management in patients with breast cancer: current standards and emerging strategiesBreast201221181921958673
   PubMed Web of Science ®Google Scholar
• BenzaidIMonkkonenHStresingVHigh phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivoCancer Res201171134562457221646473
   PubMed Web of Science ®Google Scholar
• LeeMVFongEMSingerFRGuenetteRSBisphosphonate treatment inhibits the growth of prostate cancer cellsCancer Res20016162602260811289137
   PubMed Web of Science ®Google Scholar
• SenaratneSGPirianovGMansiJLArnettTRColstonKWBisphosphonates induce apoptosis in human breast cancer cell linesBr J Cancer20008281459146810780527
   PubMed Web of Science ®Google Scholar
• ClezardinPBisphosphonates’ antitumor activity: an unravelled side of a multifaceted drug classBone2011481717920655399
   PubMed Web of Science ®Google Scholar
• GiraduoEHanahanDZoledronic acid inhibits angiogenesis and impairs tumorigenesis in a mouse model of cervical carcinogenesisHaematological Reports200633941
   Google Scholar
• AlmubarakHJonesAChaisuparatRZhangMMeillerTFScheperMAZoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancersJ Carcinog201110221297922
   PubMedGoogle Scholar
• KunzmannVWilhelmMAdjuvant zoledronic acid for breast cancer: mechanism of action?Lancet Oncol2011121199199221968221
   PubMed Web of Science ®Google Scholar
• CiminiEPiacentiniPSacchiAZoledronic acid enhances Vdelta2 T-lymphocyte antitumor response to human glioma cell linesInt J Immunopathol Pharmacol201124113914821496396
   PubMed Web of Science ®Google Scholar
• CaragliaMMarraMNaviglioSBottiGAddeoRAbbruzzeseAZoledronic acid: an unending tale for an antiresorptive agentExpert Opin Pharmacother201011114115420001436
   PubMed Web of Science ®Google Scholar
• SalzanoGMarraMPorruMSelf-assembly nanoparticles for the delivery of bisphosphonates into tumorsInt J Pharm20114031–229229721055454
   PubMed Web of Science ®Google Scholar
• ScheperMChaisuparatRCullenKMeillerTA novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosisFibrogenesis Tissue Repair20103620359336
   PubMedGoogle Scholar
• FarokhzadOCLangerRImpact of nanotechnology on drug deliveryACS Nano200931162019206243
   PubMed Web of Science ®Google Scholar
• AgratiCMarianecciCSennatoSMulticompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid deliveryNanomedicine2011715316121034859
   PubMed Web of Science ®Google Scholar
• van RooijenNvan Kesteren-HendrikxEClodronate liposomes: perspectives in research and therapeuticsJ Liposome Res200212819412604042
   PubMed Web of Science ®Google Scholar
• DanenbergHDGolombGGroothuisALiposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbitsCirculation2003108222798280414610008
   PubMed Web of Science ®Google Scholar
• MarraMSalzanoGLeonettiCNanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomesNanomedicine20117695596421453789
   PubMed Web of Science ®Google Scholar
• GuoSHuangLNanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapyJ Nanomater20112011
   Web of Science ®Google Scholar
• HafnerACorthesyBTextorMMerkleHTuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signalingBiomaterials201132102651266121216459
   PubMed Web of Science ®Google Scholar
• ZhengYAnHYaoMScaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophagesJ Immunol2010184116447645620435932
   PubMed Web of Science ®Google Scholar
• BeschRPoeckHHohenauerTProapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cellsJ Clin Invest200911982399241119620789
   PubMed Web of Science ®Google Scholar
• Alonso-CurbeloDSoengasMSSelf-killing of melanoma cells by cytosolic delivery of dsRNA: wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cellsAutophagy20106114815019923903
   PubMed Web of Science ®Google Scholar
• ChengYSXuFAnticancer function of polyinosinic-polycytidylic acidCanc Biol Ther2011101212191223
   Web of Science ®Google Scholar
• TormoDChecinskaAAlonso-CurbeloDTargeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsCancer Cell200916210311419647221
   PubMed Web of Science ®Google Scholar
• JordanMSchallhornAWurmFMTransfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formationNucleic Acid Res19962445966018604299
   PubMed Web of Science ®Google Scholar
• LiJChenYCTsengYCMozumdarSHuangLBiodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA deliveryJ Control Release2010142341642119919845
   PubMed Web of Science ®Google Scholar
• ZhangMKataokaKNano-structured composites based on calcium phosphate for cellular delivery of therapeutic and diagnostic agentsNanotoday200946508517
   Web of Science ®Google Scholar
• BishtSBhaktaGMitraSMaitraApDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene deliveryInt J Pharm2005288115716815607268
   PubMed Web of Science ®Google Scholar
• SokolovaVVRadtkeIHeumannREppleMEffective transfection of cells with multi-shell calcium phosphate-DNA nanoparticlesBiomaterials200627163147315316469375
   PubMed Web of Science ®Google Scholar
• SilvaCGracaMSombraAValenteMStructural and electrical study of calcium phosphate obtained by a microwave radiation assisted procedurePhysica B Condens Matter20094048–1115031508
   Web of Science ®Google Scholar
• ChoJSKoYNKooHYKangYCSynthesis of nano-sized biphasic calcium phosphate ceramics with spherical shape by flame spray pyrolysisJ Mater Sci Mater Med20102141143114920052521
   PubMed Web of Science ®Google Scholar
• LiKTjongSCHydrothermal synthesis and biocompatibility of hydroxyapatite nanorodsJ Nanosci Nanotechnol20111112104441044822408923
   PubMed Web of Science ®Google Scholar
• XuHHMoreauJLSunLChowLCNanocomposite containing amorphous calcium phosphate nanoparticles for caries inhibitionDent Mater201127876276921514655
   PubMed Web of Science ®Google Scholar
• ThachepanSLiMMannSMesoscale crystallization of calcium phosphate nanostructures in protein (casein) micellesNanoscale20102112400240521080570
   PubMed Web of Science ®Google Scholar
• DasguptaSBoseSReverse micelle-mediated synthesis and characterization of tricalcium phosphate nanopowder for bone graft applicationsJ Am Ceram Soc2009921125282536
   Web of Science ®Google Scholar
• HanJTanTLooJUtilizing inverse micelles to synthesize calcium phosphate nanoparticles as nano-carriersJ Nanopart Res201113834413454
   Web of Science ®Google Scholar
• ShumHBandyopadhyayABoseSWeitzDDouble emulsion droplets as microreactors for synthesis of mesoporous hydroxyapatiteChem Mater2009212255485555
   Web of Science ®Google Scholar
• ErgunCEvisZWebsterTSahinFCSynthesis and microstructural characterization of nano-size calcium phosphates with different stoichiometryCeram Int201137971977
   Web of Science ®Google Scholar
• SokolovaVKnuschkeTKovtunABuerJEppleMWestendorfAThe use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activationBiomaterials201031215627563320417963
   PubMed Web of Science ®Google Scholar
• ZhouCYuBYangXLipid-coated nano-calcium-phosphate (LNCP) for gene deliveryInt J Pharm20103921–220120820214964
   PubMed Web of Science ®Google Scholar
• ShmeedaHAmitayYGorinJTzemachDDelivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cellsJ Control Release20101461768320462513
   PubMed Web of Science ®Google Scholar
• MarraMSalzanoGLeonettiCNew self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative studyBiotechnol Adv201230130230921741464
   PubMed Web of Science ®Google Scholar
• SudimackJJGuoWTjarksWLeeRJA novel pH-sensitive liposome formulation containing oleyl alcoholBiochim Biophys Acta200215641313712100993
   PubMed Web of Science ®Google Scholar
• KimCWYunYPLeeHJHwangYSKwonIKLeeSCIn situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesisJ Control Release20101471455320600398
   PubMed Web of Science ®Google Scholar
• ChengYSXuFAnticancer function of polyinosinic-polycytidylic acidCancer Biol Ther2010101219122320930504
   PubMed Web of Science ®Google Scholar
• ForteGRegaAMorelloSPolyinosinic-polycytidylic acid limits tumor outgrowth in a mouse model of metastatic lung cancerJ Immunol2012188115357536422516955
   PubMed Web of Science ®Google Scholar
• SalaunBCosteIRissoanMCLebecqueSJRennoTTLR3 can directly trigger apoptosis in human cancer cellsJ Immunol200617684894490116585585
   PubMed Web of Science ®Google Scholar
• HirabayashiKYanoJInoueTInhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activityCancer Res199959174325433310485480
   PubMed Web of Science ®Google Scholar
• SokolovaVEppleMInorganic nanoparticles as carriers of nucleic acids into cellsAngew Chem Int Ed Engl20084781382139518098258
   PubMed Web of Science ®Google Scholar
• GrahamFLvan der EbAJA new technique for the assay of infectivity of human adenovirus 5 DNAVirology19735224564674705382
   PubMed Web of Science ®Google Scholar
• ShirAOgrisMRoedlWWagnerELevitzkiAEGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in miceClin Cancer Res20111751033104321196415
   PubMed Web of Science ®Google Scholar
• KublerKtho PeschCGehrkeNImmunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cellsEur J Immunol201141103028303921728171
   PubMed Web of Science ®Google Scholar
• WuCYYangHYMonieAIntraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumorsCancer Immunol Immunother20116081085109621526359
   PubMed Web of Science ®Google Scholar
• InaoTHarashimaNMonmaHAntitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancerBreast Cancer Res Treat201213418910022203435
   PubMed Web of Science ®Google Scholar
• HarashimaNInaoTImamuraROkanoSSudaTHaradaMRoles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cellsCancer Immunol Immunother201261566767622038398
   PubMed Web of Science ®Google Scholar
• SteelmanAJLiJpoly(I:C) promotes TNFalpha/TNFR1-dependent oligodendrocyte death in mixed glial culturesJ Neuroinflammation201188921812954
   PubMed Web of Science ®Google Scholar
• NgoiSMSt RoseMCMenoretAMPresensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsivenessProc Natl Acad Sci U S A201210926104861049122689946
   PubMed Web of Science ®Google Scholar
• MorahanPSMunsonAERegelsonWCommerfordSLHamiltonLDAntiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular sizeProc Natl Acad Sci U S A19726948428464337241
   PubMed Web of Science ®Google Scholar